Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
The RNS date was the 16th of Jan and its within 30 calendar days from when Vlad submitted.
Vlad could have submitted prior but only received the confirmation it on 15th or 16th.
FDA could have notified Vlad on 15th of receiving on the 13th, nobody knows.
Its just clear that FDA state within 30 Calendar Days they will respond, then its as quick as Vlad can work to release an RNS
What a week and nothing I can add to the sentiment that people are feeling.
I am an optimistic person, so always look for some light at the end of the tunnel. Activ-2 is key now and I wonder if our friend Dr Castro is going to be talking soon. It would be great to hear if he thinks the steroid in conjunction with SNG effected the trials?
RM will come out swinging in my opinion, he has always been straight in my view and with all the regulation, has his hands tied. If he was a slippery character, he would have sold his shares along with the other millionaires (not any more) and not allowed his Directors missus to invest.
SNG was always a COPD play and the data they have obtained will no doubt support future development/trials. They have spent a small fortune but also have cash in bank to fund further work, without diluting the share price.
Good luck all and hope you are all in good health.
With a new variant and the world press jumping back on the bandwagon. (Not standard daily updates) SNG has to come out of the dark and into the fight. We have all been here for quite sometime and the fundamentals are clear (we believe) and it will only take one RNS to catapult this share.
Any government whom puts an order in will have a domino effect and SNG will be on the lips of all news channels.
I really hope we (UK) dont make the mistakes of the past 18 months and take action now, rather than when its too late. The economy will struggle with another Lockdown and mass travel restrictions. Our health service and those around the globe need all the help they can get.
Lets see if RM has been in deep conversation and able to share a great RNS that SNG is going to be used as part of Emergency needs.
IMHO
Only thing changed is date and a few more Hospitals added
https://clinicaltrials.gov/ct2/show/study/NCT04732949?recrs=a&cond=covid-19&age=12&phase=123&draw=8
As a little PI, whom has been invested for a while (before mad monday). I have a few thoughts:
1) if 80% of patients subscribed, does this mean the data has been analysed already and will speed up the end the point
2) Is RM cagey because he has seen the data and cant risk the reputation of SNG by letting the cat out the bag (positive or negative)
3) Supply chain is ready to go, so does he know its imminent?
4) Has this data for the 80% been shared with US activ trial?
The SP is always disappointing when it drops but happy to keep faith and keep my pot of shares. Polar no doubt will be lapping those cheap shares up.
The cash raised last year included manufacturing and if they have stockpiled then they are ready to go (on successful results)
The US trial is being funded by them if i have read correctly and therefore isnt eating into the 80m.
An update would be nice on the cash front but 80m is a lot of monies to burn through.
Latest report suggests a few more hospitals around the world added
https://clinicaltrials.gov/ct2/history/NCT04732949?A=5&B=6&C=merged#StudyPageTop
Latest updates in Link and no change on completion date.
Looks like a few more Hospitals added to the list. I'm sure some of you may have seen the additions earlier but I like the facility of comparing side by side versus previous month/updates.
https://clinicaltrials.gov/ct2/history/NCT04732949?A=4&B=5&C=Side-by-Side#StudyPageTop
Based on my understanding and reading of the Trials, the estimated completion date is the 1st of Oct 2021, which according definition on NIAID, is the the date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "estimated" study completion date is the date that the researchers think will be the study completion date.
The Study states patients will be monitored for up to 90 days, which with simple math suggests that the last patient should have been dosed as part of the Phase 3 NIAID trial. (obviously estimate dates)
https://clinicaltrials.gov/ct2/show/NCT04732949?recrs=a&cond=covid-19&age=12&phase=123&draw=8&rank=140
With a little time to continue the research, I went back to the RNS and read the websites stated in the release earlier in the year. Interesting that the clinical trials has an estimated end date of 1/10/21 and suggests that each patient would be 6 months in the trial.
I'm sure more experienced and dedicated holders have already read in great detail, but does state a Phase 3 in the description and appears to be updated on the 1st of the month. Not long I feel before we receive results and I guess it will then be peer reviewed on top of that.
https://clinicaltrials.gov/ct2/show/study/NCT04732949?term=sng001&draw=2&rank=2#contacts
Did anyone catch the news on India where the testing reflected Negative even though people had Covid. Nobody knows if it is a new variance that is avoiding detection or bad testing equipment. Scary thought that a Covid Test says negative and a new strain that could have a global impact.
Wonder if this would impact Vaccine Roll Out and how SNG would fair?